Rupert Vessey insider trades

Open-market stock purchases and sales by Rupert Vessey, Director at BIO-TECHNE Corp, from SEC Form 4 filings since Aug 1, 2016.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • TECH BIO-TECHNE Corp: other filings, last Oct 24, 2024
  • BMY Bristol Myers Squibb Co: 13 sales, last May 3, 2023
  • CELG Celgene Corp /de/: 4 sales, last Nov 20, 2019

Get free alerts when Rupert Vessey files a new trade →